AROAF (Aroa Biosurgery) Total Assets: $70.60 Mil (As of Mar. 2026)


AROAF Aroa Biosurgery Ltd AROAF
39 GF Score
Price $0.52
GF Value $0.71
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Aroa Biosurgery Total Assets?

Aroa Biosurgery AROAF +35.24% 39 Total Assets is $70.60 Mil as of Mar. 2026. GuruFocus rates AROAF with a GF Score™ of 39/100 and a GF Value™ of $0.71 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Aroa Biosurgery's Total Assets for the quarter that ended in Mar. 2026 was $70.60 Mil.

During the past 12 months, Aroa Biosurgery's average Total Assets Growth Rate was -1.00% per year. During the past 3 years, the average Total Assets Growth Rate was 5.70% per year. During the past 5 years, the average Total Assets Growth Rate was 14.90% per year.

During the past 7 years, Aroa Biosurgery's highest 3-Year average Total Assets Growth Rate was 23.70%. The lowest was 5.70%. And the median was 16.70%.

Total Assets is connected with ROA %. Aroa Biosurgery's annualized ROA % for the quarter that ended in Mar. 2026 was 10.60%. Total Assets is also linked to Revenue through Asset Turnover. Aroa Biosurgery's Asset Turnover for the quarter that ended in Mar. 2026 was 0.50.

Aroa Biosurgery  (OTCPK:AROAF) Total Assets Explanation

Total Assets is connected with ROA %.

Aroa Biosurgery's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=7.076/( (62.863+70.599)/ 2 )
=7.076/66.731
=10.60 %

Note: The Net Income data used here is two times the semi-annual (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Aroa Biosurgery's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=33.325/( (62.863+70.599)/ 2 )
=33.325/66.731
=0.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Aroa Biosurgery Total Assets Related Terms

Aroa Biosurgery Total Assets Historical Data

* Premium members only.

The historical data trend for Aroa Biosurgery's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aroa Biosurgery Total Assets Chart

Aroa Biosurgery Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Assets
Get a 7-Day Free Trial 77.22 72.81 66.81 62.34 70.60

Aroa Biosurgery Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.81 65.72 62.34 62.86 70.60
AROAF
39GF Score
Aroa Biosurgery Ltd AROAF
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aroa Biosurgery Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Aroa Biosurgery's Total Assets for the fiscal year that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (A: Mar. 2026 )+Total Liabilities (A: Mar. 2026 )
=58.132+12.467
=70.60

Aroa Biosurgery's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=58.132+12.467
=70.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $70.60 Mil mean?
Aroa Biosurgery (AROAF) has a Total Assets of $70.60 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Aroa Biosurgery and its competitors.
Is Aroa Biosurgery's Total Assets too high?
Aroa Biosurgery's current Total Assets is $70.60 Mil. Overall, Aroa Biosurgery has a GF Score™ of 39/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aroa Biosurgery's Total Assets compare to ABT and SYK?
Aroa Biosurgery's Total Assets of $70.60 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Aroa Biosurgery and its competitors. Aroa Biosurgery's current Total Assets is $70.60 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aroa Biosurgery stock overvalued right now?
Based on GuruFocus' analysis, Aroa Biosurgery (AROAF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.71, compared to a current price of $0.52 — trading 26.8% below its estimated fair value. The current Total Assets is $70.60 Mil. Aroa Biosurgery's overall GF Score™ is 39/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Aroa Biosurgery (AROAF), the current Total Assets is $70.60 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aroa Biosurgery (AROAF) Overvalued in 2026?

Based on GuruFocus' analysis, Aroa Biosurgery stock appears to be undervalued. The current stock price of $0.52 is trading 26.8% below its estimated GF Value™ of $0.71. GuruFocus considers Aroa Biosurgery to be Modestly Undervalued.

Key valuation signals for AROAF:

  • Total Assets: $70.60 Mil
  • GF Value™: $0.71 vs. price of $0.52 (26.8% below fair value)
  • GF Score™: 39/100 with 1 warning sign

No single metric tells the full story. See the AROAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aroa Biosurgery Business Description

Other Exchanges ARX:Australia
Address 64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022
Aroa Biosurgery Ltd is a soft tissue regeneration company that develops, manufactures, and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The company is in the business of developing, manufacturing, and selling soft tissue repair products. The company's principal market is the United States, where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery, and trauma/limb salvage/tumor surgery.
39GF Score

Get the complete analysis for AROAF

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.52
Price
$0.71
GF Value